3 completed, 1 terminated. 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow VeroScience: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy Cycloset - Type 2 Diabetes | Phase 4 | Completed | The University of Texas Health Science Center at San Antonio | 23 | 2014-06-01 | 2019-06-21 |
| Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects Bromocriptine mesylate - Type 2 Diabetes | Phase 1 | Completed | VeroScience | 18 | 2014-01-01 | 2016-08-29 |
| Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin Bromocriptine Mesylate - Type 2 Diabetes | Phase 3 | Terminated | VeroScience | 66 | 2005-02-01 | 2016-05-09 |
| Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes Cycloset, Usual Diabetes Therapy plus placebo - Type 2 Diabetes Mellitus | Phase 3 | Completed | VeroScience | 3095 | 2004-07-01 | 2016-06-10 |
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus (2)
Bromocriptine (4)
United States (2)
Bindu Chamarthi, MD MMSc (1) · Michael Gaziano (1) · Ralph A DeFronzo, MD (1) · Richard E Scranton, MD (1) · Richard E Scranton, MD MPH (1)
PMID 20332352, PMID 23316290, PMID 26060823, PMID 27687032, PMID 28374645